Mylan-Biocon’s Ogivri First Off Block In Australia But Competition In Sight

 
• By Anju Ghangurde
3D_Australia
First Biosimilar Trastuzumab Debuts In Australia • Source: Shutterstock

More from Focus On Asia

More from Scrip